NCT02392572 2026-03-12
ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × TIC10 compound × Other hematologic neoplasm × Clear all